GSK3β allows crosstalk between PI3K/AKT and Wnt pathways and antagonizes Wnt signaling by forming protein complexes with Axin1 and CK1 to polyubiquitinate β-catenin, the central component of canonical Wnt signaling, to inhibit cancer cell proliferation and invasion (43, 44). The gene discussed is PIK3CA; the disease is cancer.